JP2019526541A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526541A5 JP2019526541A5 JP2019505187A JP2019505187A JP2019526541A5 JP 2019526541 A5 JP2019526541 A5 JP 2019526541A5 JP 2019505187 A JP2019505187 A JP 2019505187A JP 2019505187 A JP2019505187 A JP 2019505187A JP 2019526541 A5 JP2019526541 A5 JP 2019526541A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- terpene fraction
- cannabis extract
- cancer
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003505 terpenes Chemical class 0.000 claims 20
- 235000007586 terpenes Nutrition 0.000 claims 20
- 239000008194 pharmaceutical composition Substances 0.000 claims 16
- 241000218236 Cannabis Species 0.000 claims 14
- 206010028980 Neoplasm Diseases 0.000 claims 10
- 201000011510 cancer Diseases 0.000 claims 10
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 10
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 8
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 8
- 229950011318 cannabidiol Drugs 0.000 claims 8
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 8
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 8
- 229960004242 dronabinol Drugs 0.000 claims 7
- TWKHUZXSTKISQC-UHFFFAOYSA-N 2-(5-methyl-2-prop-1-en-2-ylphenyl)-5-pentylbenzene-1,3-diol Chemical compound OC1=CC(CCCCC)=CC(O)=C1C1=CC(C)=CC=C1C(C)=C TWKHUZXSTKISQC-UHFFFAOYSA-N 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims 6
- 229940124597 therapeutic agent Drugs 0.000 claims 5
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 claims 4
- 229930003827 cannabinoid Natural products 0.000 claims 4
- 239000003557 cannabinoid Substances 0.000 claims 4
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 claims 4
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 claims 3
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 claims 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims 3
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 claims 3
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 claims 3
- 229930006722 beta-pinene Natural products 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 claims 3
- 229930007744 linalool Natural products 0.000 claims 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 claims 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 claims 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims 2
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 claims 2
- NVEQFIOZRFFVFW-RGCMKSIDSA-N caryophyllene oxide Chemical compound C=C1CC[C@H]2O[C@]2(C)CC[C@H]2C(C)(C)C[C@@H]21 NVEQFIOZRFFVFW-RGCMKSIDSA-N 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 claims 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 239000004474 valine Substances 0.000 claims 2
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 claims 2
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 claims 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 claims 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 claims 1
- VITZNDKHSIWPSR-HZPDHXFCSA-N (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-4-carboxylic acid Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=C(C(O)=O)C(CCCCC)=CC(O)=C3[C@@H]21 VITZNDKHSIWPSR-HZPDHXFCSA-N 0.000 claims 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 235000005273 Canna coccinea Nutrition 0.000 claims 1
- 240000008555 Canna flaccida Species 0.000 claims 1
- REOZWEGFPHTFEI-JKSUJKDBSA-N Cannabidivarin Chemical compound OC1=CC(CCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 REOZWEGFPHTFEI-JKSUJKDBSA-N 0.000 claims 1
- 241001471082 Colocasia bobone disease-associated cytorhabdovirus Species 0.000 claims 1
- TWVJWDMOZJXUID-SDDRHHMPSA-N Guaiol Chemical compound C1([C@H](CC[C@H](C2)C(C)(C)O)C)=C2[C@@H](C)CC1 TWVJWDMOZJXUID-SDDRHHMPSA-N 0.000 claims 1
- 208000017891 HER2 positive breast carcinoma Diseases 0.000 claims 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 claims 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims 1
- 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 claims 1
- REOZWEGFPHTFEI-UHFFFAOYSA-N cannabidivarine Natural products OC1=CC(CCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 REOZWEGFPHTFEI-UHFFFAOYSA-N 0.000 claims 1
- RSYBQKUNBFFNDO-UHFFFAOYSA-N caryophyllene oxide Natural products CC1(C)CC2C(=C)CCC3OC3(C)CCC12C RSYBQKUNBFFNDO-UHFFFAOYSA-N 0.000 claims 1
- 210000003918 fraction a Anatomy 0.000 claims 1
- TWVJWDMOZJXUID-QJPTWQEYSA-N guaiol Natural products OC(C)(C)[C@H]1CC=2[C@H](C)CCC=2[C@@H](C)CC1 TWVJWDMOZJXUID-QJPTWQEYSA-N 0.000 claims 1
- 208000027706 hormone receptor-positive breast cancer Diseases 0.000 claims 1
- 229940095045 isopulegol Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 claims 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims 1
- 150000007823 ocimene derivatives Chemical class 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 claims 1
- 239000008159 sesame oil Substances 0.000 claims 1
- 235000011803 sesame oil Nutrition 0.000 claims 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 claims 1
- 208000022679 triple-negative breast carcinoma Diseases 0.000 claims 1
- -1 δ-s-calene Chemical compound 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662370299P | 2016-08-03 | 2016-08-03 | |
| US62/370,299 | 2016-08-03 | ||
| AU2017901222A AU2017901222A0 (en) | 2017-04-04 | Cannabis composition | |
| AU2017901222 | 2017-04-04 | ||
| AU2017902065A AU2017902065A0 (en) | 2017-05-31 | Cannabis composition | |
| AU2017902065 | 2017-05-31 | ||
| PCT/AU2017/050817 WO2018023166A1 (en) | 2016-08-03 | 2017-08-03 | Cannabis composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020204014A Division JP7139559B2 (ja) | 2016-08-03 | 2020-12-09 | 大麻組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019526541A JP2019526541A (ja) | 2019-09-19 |
| JP2019526541A5 true JP2019526541A5 (cg-RX-API-DMAC7.html) | 2020-01-23 |
Family
ID=65524553
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019505187A Pending JP2019526541A (ja) | 2016-08-03 | 2017-08-03 | 大麻組成物 |
| JP2020204014A Active JP7139559B2 (ja) | 2016-08-03 | 2020-12-09 | 大麻組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020204014A Active JP7139559B2 (ja) | 2016-08-03 | 2020-12-09 | 大麻組成物 |
Country Status (15)
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210013645A (ko) | 2016-08-03 | 2021-02-04 | 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 | 카나비스 조성물 |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| CN110944632A (zh) | 2017-06-19 | 2020-03-31 | 塞尔达治疗手术有限公司 | 睡眠障碍组合物及其治疗 |
| CA3103178A1 (en) * | 2017-06-27 | 2019-01-03 | Enviro BioMedical Laboratories Inc. | Blended cannabis compounds and methods of making the same |
| US20200276155A1 (en) * | 2017-09-15 | 2020-09-03 | Zelda Therapeutics Operations Pty Ltd | Composition and method for treating autism |
| EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| WO2019199861A2 (en) * | 2018-04-09 | 2019-10-17 | Ellevet Sciences | Hemp extract for treatment of pain in animals |
| WO2019227167A1 (en) * | 2018-06-01 | 2019-12-05 | The University Of Sydney | Compositions and treatments |
| EP3807385A1 (en) * | 2018-06-14 | 2021-04-21 | Biosoma B.V. | Process for the extraction of oil-soluble components from plant material |
| US11040932B2 (en) | 2018-10-10 | 2021-06-22 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| WO2020084423A1 (en) * | 2018-10-24 | 2020-04-30 | Radient Technologies Innovations Inc. | Extraction-based contract execution |
| WO2020121312A1 (en) * | 2018-12-12 | 2020-06-18 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl) |
| NL2022615B1 (en) * | 2019-02-21 | 2020-08-31 | Patrick Alexander Unger | Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight |
| CN113784704A (zh) * | 2019-04-17 | 2021-12-10 | 诺狄更斯公司 | 快速崩解大麻素片剂 |
| EP4041000A1 (en) * | 2019-10-09 | 2022-08-17 | Nicoventures Trading Limited | Aerosolisable material |
| US12011471B2 (en) * | 2019-12-19 | 2024-06-18 | Atlas365 Incorporated | Extracts enriched with polyphenolic compounds and related methods |
| CN115605289A (zh) * | 2020-04-29 | 2023-01-13 | 利加尔有限合伙公司（Nz） | 印迹聚合物及其使用方法 |
| MX2022015799A (es) * | 2020-06-12 | 2023-04-11 | Zelira Therapeutics Operations Pty Ltd | Composicion y metodo para el tratamiento del dolor cronico. |
| KR20220126653A (ko) * | 2021-03-08 | 2022-09-16 | 주식회사 엘지생활건강 | 칸나비게롤을 포함하는 조성물 |
| IL307444A (en) * | 2021-04-05 | 2023-12-01 | The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo | Preparations and methods for the treatment of cancer |
| US12440454B2 (en) | 2022-02-01 | 2025-10-14 | Portland Technology Holdings Llc | Pharmaceutical compositions containing hemp extract for administration to felines and related methods |
| WO2025231524A1 (en) * | 2024-05-08 | 2025-11-13 | Heyday RX Pty Ltd | Cannabinoid compositions |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10051427C1 (de) * | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
| GB2418612A (en) | 2004-10-01 | 2006-04-05 | Gw Pharma Ltd | Inhibition of tumour cell migration with cannabinoids |
| KR20070118069A (ko) | 2004-12-09 | 2007-12-13 | 인시스 테라퓨틱스, 인코포레이티드 | 실온에서 안정한 드로나비놀 제형 |
| WO2007032962A2 (en) | 2005-09-09 | 2007-03-22 | University Of Kentucky | Compositions and methods for intranasal delivery of tricyclic cannabinoids |
| US8980940B2 (en) * | 2006-11-10 | 2015-03-17 | Johnson Matthey Public Limited Company | Stable cannabinoid compositions and methods for making and storing them |
| GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| GB201117956D0 (en) | 2011-10-18 | 2011-11-30 | Otsuka Pharma Co Ltd | Phytocannabinoids for use in the treatment of breast cancer |
| CN104619318A (zh) * | 2012-05-03 | 2015-05-13 | 回音制药公司 | 含有δ9-四氢大麻酚的大麻植物分离物及其制备方法 |
| US10792318B2 (en) | 2013-03-14 | 2020-10-06 | Sc Laboratories, Inc. | Bioactive concentrates and uses thereof |
| WO2014145490A2 (en) | 2013-03-15 | 2014-09-18 | Biotech Institute, Llc | Breeding, production, processing and use of specialty cannabis |
| HRP20191097T1 (hr) | 2013-10-29 | 2019-09-20 | Biotech Institute, Llc | Uzgoj, proizvodnja, obrada i upotreba specijalnog kanabisa |
| US9044390B1 (en) | 2014-04-17 | 2015-06-02 | Gary J. Speier | Pharmaceutical composition and method of manufacturing |
| WO2015200049A1 (en) | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
| US11793769B2 (en) * | 2014-08-25 | 2023-10-24 | Jai Shankar Sukul | Device with compositions for delivery to the lungs, the oral mucosa and the brain |
| BR112017008301B1 (pt) * | 2014-10-21 | 2021-12-07 | United Cannabis Corp | Extratos de cannabis e métodos de sua preparação e uso |
| AU2015360349B2 (en) * | 2014-12-12 | 2020-10-08 | Ojai Energetics Pbc | Microencapsulated cannabinoid compositions |
| WO2016105514A1 (en) * | 2014-12-23 | 2016-06-30 | Biotech Institute, Llc | A reliable and robust method for the analysis of cannabinoids and terpenes in cannabis |
| EP3250200A4 (en) | 2015-01-31 | 2018-09-19 | Constance Therapeutics, Inc. | Methods for preparation of cannabis oil extracts and compositions |
| KR20210013645A (ko) | 2016-08-03 | 2021-02-04 | 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 | 카나비스 조성물 |
| EP3493799A4 (en) | 2016-08-03 | 2020-04-01 | Zelda Therapeutics Operations Pty Ltd | CANNABIS |
-
2017
- 2017-08-03 KR KR1020217033707A patent/KR102447510B1/ko active Active
- 2017-08-03 CN CN201780060641.8A patent/CN109789123A/zh active Pending
- 2017-08-03 CA CA3031300A patent/CA3031300A1/en active Pending
- 2017-08-03 JP JP2019505187A patent/JP2019526541A/ja active Pending
- 2017-08-03 WO PCT/AU2017/050817 patent/WO2018023166A1/en not_active Ceased
- 2017-08-03 MX MX2019001286A patent/MX386086B/es unknown
- 2017-08-03 KR KR1020197005323A patent/KR20190034576A/ko not_active Ceased
- 2017-08-03 PE PE2021001332A patent/PE20230607A1/es unknown
- 2017-08-03 PE PE2019000307A patent/PE20200677A1/es unknown
- 2017-08-03 AU AU2017305103A patent/AU2017305103B2/en active Active
- 2017-08-03 KR KR1020227032758A patent/KR20220132674A/ko not_active Ceased
- 2017-08-03 BR BR112019001794-1A patent/BR112019001794A2/pt not_active Application Discontinuation
- 2017-08-03 EP EP17836100.2A patent/EP3493800A4/en not_active Withdrawn
- 2017-08-03 SG SG11201900501RA patent/SG11201900501RA/en unknown
- 2017-08-03 US US15/780,579 patent/US11304925B1/en active Active
-
2018
- 2018-07-03 AU AU2018100920A patent/AU2018100920B4/en not_active Expired
-
2019
- 2019-01-24 IL IL264458A patent/IL264458B/en active IP Right Grant
- 2019-01-31 CL CL2019000266A patent/CL2019000266A1/es unknown
- 2019-02-01 CO CONC2019/0001043A patent/CO2019001043A2/es unknown
- 2019-05-20 AU AU2019203529A patent/AU2019203529B2/en active Active
-
2020
- 2020-12-09 JP JP2020204014A patent/JP7139559B2/ja active Active
-
2021
- 2021-07-16 AU AU2021205115A patent/AU2021205115B2/en active Active
-
2022
- 2022-03-16 US US17/696,684 patent/US20220202767A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019526541A5 (cg-RX-API-DMAC7.html) | ||
| JP2020524151A5 (cg-RX-API-DMAC7.html) | ||
| JP7139559B2 (ja) | 大麻組成物 | |
| JP2019523282A5 (cg-RX-API-DMAC7.html) | ||
| AU2017307644B2 (en) | Cannabis composition | |
| JP2019523283A5 (cg-RX-API-DMAC7.html) | ||
| US11717527B2 (en) | Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen | |
| FI3743053T3 (fi) | Kannabinoidien käyttö epilepsian hoidossa | |
| US20230087359A1 (en) | Cannabinoid compositions and methods of use thereof | |
| IL198200A (en) | Use of estradiol valerate or 17beta-estradiol in combination with dienogest for oral therapy for maintaining and/or increasing the female libido | |
| US20210128518A1 (en) | Cannabinoid-containing dermatological compositions and methods using same | |
| BR112021021029A2 (pt) | Preparação de canabidiol, e, método para tratar um paciente que sofre de crises associadas ao complexo de esclerose tuberosa | |
| AU2016270753B2 (en) | Compositions for treatment of atrophic vaginitis, peri-and post-menopausal dyspareunia, and/or oophorectomized females and treatment methods therewith | |
| JPWO2021003341A5 (cg-RX-API-DMAC7.html) | ||
| Vilos et al. | The levonorgestrel intrauterine system is an effective treatment in selected obese women with abnormal uterine bleeding | |
| JPWO2022074541A5 (cg-RX-API-DMAC7.html) | ||
| WO2022233833A1 (en) | Nasal sleep formulation | |
| CN101264096B (zh) | 人参皂苷Rg1在制备生精产品中的应用 | |
| EP4208164A1 (en) | Composition comprising cannabinoids, and/or terpens, and methods of using same | |
| TWI787221B (zh) | 眼科用組成物及其製造方法 | |
| JP2016518424A (ja) | ヘルペス処置のための薬剤と方法 | |
| US11931333B1 (en) | Topical treatment of herpes infections | |
| US20210393650A1 (en) | Designing Treatments for Chemotherapy-Induced and Age-Related Menopausal Symptoms Using Combinations of Natural Products and Prescription Medications | |
| CN104490905B (zh) | 一种用于治疗痔疮的乳膏及制备方法 | |
| JPWO2022157385A5 (cg-RX-API-DMAC7.html) |